Sensalė - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 38,683 | 21,988 | 46,517 | 45,959 | 54,691 | 55,017 | 45,992 | 77,311 |
| Profit before tax | -35,732 | 17,025 | 19,721 | 7,920 | 8,989 | 12,798 | 5,068 | 50,760 |
| Net profit | -35,732 | 17,025 | 19,512 | 7,548 | 8,363 | 12,150 | 4,817 | 47,885 |
| Equity | 88,883 | 105,908 | 125,420 | 97,968 | 104,011 | 110,661 | 102,978 | 139,483 |
| Liabilities | 23,504 | 16,300 | 12,436 | 17,237 | 37,786 | 18,768 | 22,674 | 42,738 |
| Non-current assets | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Current assets | 112,496 | 122,207 | 137,855 | 115,204 | 141,796 | 129,428 | 125,651 | 182,220 |
| Total assets | 112,497 | 122,208 | 137,856 | 115,205 | 141,797 | 129,429 | 125,652 | 182,221 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 5,791 | 8,941 | 5,817 |
|
Financial indicators
|
||||||||
| Revenue change y/y | -62.3% | -43.2% | +111.6% | -1.2% | +19.0% | +0.6% | -16.4% | +68.1% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | -31.8% | 13.9% | 14.2% | 6.6% | 5.9% | 9.4% | 3.8% | 26.3% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | -40.2% | 16.1% | 15.6% | 7.7% | 8.0% | 11.0% | 4.7% | 34.3% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | -92.4% | 77.4% | 41.9% | 16.4% | 15.3% | 22.1% | 10.5% | 61.9% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | -92.4% | 77.4% | 42.4% | 17.2% | 16.4% | 23.3% | 11.0% | 65.7% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | 0.3 | 0.2 | 0.1 | 0.2 | 0.4 | 0.2 | 0.2 | 0.3 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | 7,487 | 7,329 | 14,313 | 11,490 | 14,916 | 18,339 | 15,331 | 25,770 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Sensalė - Social security debts
The company had no debts to Sodra
Sensalė - VMI tax arrears
The company had no tax arrears (debts) to the State Tax Inspectorate
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Sensale, UAB (code 132951117) is a Private Limited Liability Company operating in wholesale of pharmaceutical and medical goods. In the latest financial year, 2025, the company generated revenue of €77.3K and net profit of €47.9K, with a profit margin of 61.9%. This marked a clear improvement from 2024, when revenue was €46.0K and net profit €4.8K, following 2023 revenue of €55.0K and net profit of €12.2K. Revenue increased by 68.1% year on year in 2025 and was 40.5% higher than two years earlier. The balance sheet remained modest in size, with total assets of €182.2K, equity of €139.5K and liabilities of €42.7K at the end of 2025. The equity ratio stood at 76.5% and debt to equity at 0.31, indicating a relatively low leverage position. Return on equity was 34.3% and return on assets 26.3%. Asset turnover was 0.42x. Revenue per employee was €25.8K and profit per employee €16.0K, pointing to solid productivity relative to the company’s scale.